Phase II study of spirogermanium in metastatic prostate cancer.
作者信息
Dexeus F H, Logothetis C, Samuels M L, Hossan B
出版信息
Cancer Treat Rep. 1986 Sep;70(9):1129-30.
PMID:3742495
Abstract
摘要
相似文献
1
Phase II study of spirogermanium in metastatic prostate cancer.
Cancer Treat Rep. 1986 Sep;70(9):1129-30.
2
Phase II study of spirogermanium in advanced breast cancer.
Cancer Treat Rep. 1984 Dec;68(12):1515-6.
3
[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Bull Cancer. 1986;73(1):65-7.
4
Phase I clinical trial of spirogermanium.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1051-6.
5
Phase II study of spirogermanium in the treatment of metastatic breast cancer.
Cancer Treat Rep. 1984 Sep;68(9):1197-8.
6
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
Cancer Treat Rep. 1986 May;70(5):673-4.
7
Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
Cancer Treat Rep. 1984 Oct;68(10):1305-6.
8
Phase II trial of spirogermanium for treatment of advanced breast cancer.
Cancer Treat Rep. 1983 Feb;67(2):189-90.
9
Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
Cancer Treat Rep. 1982 Aug;66(8):1667-8.
10
Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
Cancer Treat Rep. 1983 Feb;67(2):193-4.
引用本文的文献
1
Complexes of metals other than platinum as antitumour agents.
Eur J Clin Pharmacol. 1994;47(1):1-16. doi: 10.1007/BF00193472.
Zotero 插件